この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2024/12/311 分で読めます
Flamingo Pharmaceuticals Ltd.; Withdrawal of Approval of Two Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA or Agency) is withdrawing approval of two abbreviated new drug applications (ANDAs) from the holder of those ANDAs. The basis for the withdrawal is that the ANDA holder has repeatedly failed to file required annual reports for those ANDAs.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →